Friday, May 20, 2022 11:47:02 AM
Nice source:
Investor Alert: Joseph Hersey Pratt was barred for misusing the confidential information obtained from insiders at a public biopharmaceutical company
March 18, 2020 Jon Furgison
FINRA Sanctions & Allegations of Misconduct
FINRA barred Joseph Hersey Pratt (CRD #719416) located in Radnor, Pennsylvania for misusing the confidential information obtained from insiders at a public biopharmaceutical company by communicating it to several of his member firm’s customers. He failed to provide prior written notice or obtain prior approval for his solicitation of investors in private securities transactions in the company and he solicited individuals, some of whom were his customers at the firm, to invest approximately $436,000 in shares of the company.
Investor Alert: Joseph Hersey Pratt was barred for misusing the confidential information obtained from insiders at a public biopharmaceutical company
March 18, 2020 Jon Furgison
FINRA Sanctions & Allegations of Misconduct
FINRA barred Joseph Hersey Pratt (CRD #719416) located in Radnor, Pennsylvania for misusing the confidential information obtained from insiders at a public biopharmaceutical company by communicating it to several of his member firm’s customers. He failed to provide prior written notice or obtain prior approval for his solicitation of investors in private securities transactions in the company and he solicited individuals, some of whom were his customers at the firm, to invest approximately $436,000 in shares of the company.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
